oa Ischemic Optic Neuropathy in Chronic Viral Hepatitis C Treated with Interferon and Ribavirin

References

1. Abe T, Nakojimo A, Satoh N, et al., Retinopathy associated with hepatitis C virus. Rinsho Ganka Jpn J Clin Ophthalmol. 1993; 47::227–230.
   [Google Scholar]
2. Schulman Joel A, Liang Chanping, Kooragayala Lakshmana M, King John. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology. 2003; 110:2:437–442.
   [Google Scholar]
3. Hosein Sean. Sight changes reported with PEG-interferon. HIV Treatment Bulletin. 2004; 5:, , CATIE News.
   [Google Scholar]
4. Tu KL, Bowyer J, Schofield K, et al., Severe interferon associated retinopathy. Br J Ophthalmol. 2003; 87::247–248.
   [Google Scholar]
5. Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis Cjustified? Br J Ophthalmol. 2004 December; 88:12:1518–1520.
   [Google Scholar]
6. Vardizer Yoav, Linhart Yifat, Loewen stein Anat, Garzozi Hanna, Mazawi Nail, Kesler Anat. Interferon-falphaj-Associated Bilateral Simultaneous Ischemic Optic Neuropathy. Journal of Neurophthalmology. December 2003; 23:4:256–259.
   [Google Scholar]
7. Yamada H, Mizobuchi K, Isogai Y. Acute onset of ocular complications with interferon. Lancet. 1994; 343::914.
   [Google Scholar]
8. Hayasaka S, Fujii M, Yamamoto Y, Noda S, Kurome H, Sasaki M. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon a Ifa. Br J Ophthalmol. 1995; 79::150–152.
   [Google Scholar]
9. Tadokoro Y, Ohtsuki H, Okano M, Furuse T. A case of disc edema during systemic interferon therapy. Folia Ophthalmol Jpn (Ganka- Kiyo). 1995; 46::653–656.
   [Google Scholar]
10. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol. 1996; 24::38–47.
    [Google Scholar]
11. Hirokazu Ni, Yuichiro O, Kazuaki M, Waoko H, Murno H, Yoshihito H. Prednisolone, platelet- activating factor receptor antagonist, or superoxide dismutase reduced leukocyte antagonist, or superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation. Invest Ophthalmol Vis Sci. 1997; 38::811–816.
    [Google Scholar]
12. Hayreh SS, Zimmerman B, Podhajsky P, Alward Wl. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994; 117::603–624.
    [Google Scholar]